Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #1192 on Enanta Pharmaceuticals Inc (ENTA)
DewDiligence
11/13/15 2:38 PM
#1193 RE: NY1972 #1192
Street expects ABBV 2nd gen to do worse than Harvoni in the most challenging population that is generating most of the scripts.